Marit Synnestvedt

1.1k citations

19 papers · 778 indexed · h-index 14

Co-authors: Bjørn Naume Elin Borgen Gro Wiedswang Jahn M. Nesland Ellen Schlichting Hege G. Russnes Klaus Pantel Rolf Kåresen
Topics: Breast Cancer Treatment Studies (13 papers)Cancer Cells and Metastasis (12 papers)Breast Lesions and Carcinomas (5 papers)
Cited by: Cancer Research Oncology Pulmonary and Respiratory Medicine
Journals: Journal of Clinical Oncology Clinical Cancer Research Breast Cancer Research and Treatment
Partner nations: Norway United States Germany

In The Last Decade

Marit Synnestvedt

19 papers receiving 771 citations

Peers

Countries citing papers authored by Marit Synnestvedt

Since Specialization

Citations

This map shows the geographic impact of Marit Synnestvedt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marit Synnestvedt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marit Synnestvedt more than expected).

Fields of papers citing papers by Marit Synnestvedt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marit Synnestvedt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marit Synnestvedt. The network helps show where Marit Synnestvedt may publish in the future.

Co-authorship network of co-authors of Marit Synnestvedt

This figure shows the co-authorship network connecting the top 25 collaborators of Marit Synnestvedt. A scholar is included among the top collaborators of Marit Synnestvedt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marit Synnestvedt. Marit Synnestvedt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen 2020 ·Molecular Oncology ·(unknown),Bjørn Naume,Steinar Hustad,Ersilia Bifulco,Jan Terje Kvaløy,Anna Barbro Sætersdal,Marit Synnestvedt,Tone Hoel Lende,Bjørnar Gilje,Ingvil Mjaaland,(unknown),Egil Støre Blix,Gro Wiedswang,Elin Borgen,Daniel L. Hertz,(unknown),Gunnar Mellgren,Håvard Søiland	9
2	NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients 2018 ·Breast Cancer Research ·Elin Borgen,(unknown),María Soledad Sosa,Anne Renolen,Ellen Schlichting,Per Eystein Lønning,Marit Synnestvedt,Julio A. Aguirre‐Ghiso,Bjørn Naume	78
3	Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer 2017 ·Breast Cancer Research and Treatment ·(unknown),Kjetil Boye,Daehoon Park,Marit Synnestvedt,Torill Sauer,Bjørn Naume,Elin Borgen,Gunhild M. Mælandsmo	21
4	Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients 2014 ·BMC Cancer ·Bjørnar Gilje,Oddmund Nordgård,Kjersti Tjensvoll,Elin Borgen,Marit Synnestvedt,Rune Smaaland,Bjørn Naume	9
5	Clinical Outcome With Correlation to Disseminated Tumor Cell (DTC) Status After DTC-Guided Secondary Adjuvant Treatment With Docetaxel in Early Breast Cancer 2014 ·Journal of Clinical Oncology ·Bjørn Naume,Marit Synnestvedt,Ragnhild Sørum Falk,Gro Wiedswang,(unknown),Terje Risberg,Christian Kersten,Ingvil Mjaaland,(unknown),(unknown),Anna Barbro Sætersdal,(unknown),Cecilie Bendigtsen Schirmer,Erik A. Wist,Elin Borgen	66
6	Disseminated tumour cells in the bone marrow in early breast cancer: morphological categories of immunocytochemically positive cells have different impact on clinical outcome 2013 ·Breast Cancer Research and Treatment ·Marit Synnestvedt,Elin Borgen,Ellen Schlichting,Cecilie Bendigtsen Schirmer,Anne Renolen,K. E. Giercksky,Jahn M. Nesland,(unknown)	8
7	Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study 2012 ·BMC Cancer ·Marit Synnestvedt,Elin Borgen,Erik Wist,Gro Wiedswang,(unknown),Terje Risberg,Christian Kersten,Ingvil Mjaaland,(unknown),Cecilie Bendigtsen Schirmer,Jahn M. Nesland,Bjørn Naume	18
8	Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness 2012 ·Histopathology ·Hari Prasad Dhakal,Bjørn Naume,Marit Synnestvedt,Elin Borgen,Rolf Kaaresen,Ellen Schlichting,Gro Wiedswang,Assia Bassarova,Ruth Holm,Karl‐Erik Giercksky,Jahn M. Nesland	33
9	Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy 2012 ·Acta Oncologica ·Marit Synnestvedt,Elin Borgen,Hege G. Russnes,(unknown),Ellen Schlichting,Karl-Erik Giercksky,Rolf Kåresen,Jahn M. Nesland,Bjørn Naume	21
10	Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact. 2012 ·PubMed ·Hari Prasad Dhakal,Bjørn Naume,Marit Synnestvedt,Elin Borgen,Rolf Kaaresen,Ellen Schlichting,Gro Wiedswang,Assia Bassarova,Ruth Holm,Karl‐Erik Giercksky,Jahn M. Nesland	18
11	Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis 2011 ·Clinical Cancer Research ·Wolfgang Janni,Florian D. Vogl,Gro Wiedswang,Marit Synnestvedt,Tanja Fehm,Julia Jückstöck,Elin Borgen,Brigitte Rack,Stephan Braun,Harald Sommer,Erich Solomayer,Klaus Pantel,Jahn M. Nesland,Klaus Friese,Bjørn Naume	192
12	The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients 2011 ·Breast Cancer Research ·Timothy J. Molloy,Astrid J Bosma,Lars O. Baumbusch,Marit Synnestvedt,Elin Borgen,Hege G. Russnes,Ellen Schlichting,Laura J. van’t Veer,Bjørn Naume	71
13	Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern 2010 ·Breast Cancer Research and Treatment ·Katharina E. Effenberger,Elin Borgen,Christine zu Eulenburg,Kai Bartkowiak,(unknown),Marit Synnestvedt,Rolf Kaaresen,Burkhard Brandt,Jahn M. Nesland,Klaus Pantel,Bjørn Naume	33
14	The prognostic impact of occult nodal metastasis in early breast carcinoma 2009 ·Breast Cancer Research and Treatment ·Daehoon Park,Rolf Kåresen,Bjørn Naume,Marit Synnestvedt,(unknown),Torill Sauer	23
15	Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count. 2009 ·PubMed ·Hari Prasad Dhakal,Assia Bassarova,Bjørn Naume,Marit Synnestvedt,Elin Borgen,Rolf Kaaresen,Ellen Schlichting,Gro Wiedswang,Karl‐Erik Giercksky,Jahn M. Nesland	28
16	Vascularization in Primary Breast Carcinomas: Its Prognostic Significance and Relationship with Tumor Cell Dissemination 2008 ·Clinical Cancer Research ·Hari Prasad Dhakal,Bjørn Naume,Marit Synnestvedt,Elin Borgen,Rolf Kaaresen,Ellen Schlichting,Gro Wiedswang,Assia Bassarova,Karl-Erik Giercksky,Jahn M. Nesland	33
17	Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer 2007 ·Molecular Oncology ·Bjørn Naume,Xi Zhao,Marit Synnestvedt,Elin Borgen,Hege G. Russnes,Ole Christian Lingjærde,(unknown),Gro Wiedswang,Gunnar Kvalheim,Rolf Kåresen,Jahn M. Nesland,Anne‐Lise Børresen‐Dale,Thérese Sørlie	113
18	Recurrent Group A Streptococcal Genital Infection after Puerperal Sepsis 2003 ·Scandinavian Journal of Infectious Diseases ·Marit Synnestvedt,Fredrik Müller,Peter Gaustad,(unknown)	2
19	[Colorectal cancer. Location dependent symptoms?]. 1997 ·PubMed ·Marit Synnestvedt,(unknown),B Hofstad	2

About Marit Synnestvedt

Marit Synnestvedt is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 19 papers that have together received 778 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (13 papers), Cancer Cells and Metastasis (12 papers) and Breast Lesions and Carcinomas (5 papers). The work is most often cited by research in Cancer Research (419 citations), Oncology (546 citations) and Pulmonary and Respiratory Medicine (152 citations). Marit Synnestvedt has collaborated with scholars based in Norway, United States and Germany. Frequent co-authors include Bjørn Naume, Elin Borgen, Gro Wiedswang, Jahn M. Nesland, Ellen Schlichting, Hege G. Russnes, Klaus Pantel, Rolf Kåresen, Rolf Kaaresen and Tanja Fehm. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact